"It has became apparent that in order to substantially impact the number of patients enrolled in clinical trials, the community oncologist needed to be included as a partner in the process. It is well documented that cancer patients want to receive the best possible care close to home, in their community, near friends and family"

-Craig Henderson, MD
Professor of Medicine, UCSF
President/CEO, Access Oncology

More than 80 percent of all cancer care is now provided at the community level, as is 60 percent of all clinical cancer research. This significant demand for community-based cancer-care services continues to grow and to meet these evolving needs; new models for the delivery of cancer care are also emerging. With over 400 cancer drugs in the research pipeline in the US, and the fact that only 3% to 5% of cancer patients are enrolled in clinical trials, there is an urgent need to expand clinical trials outside the traditional academic setting.

Suburban Hematology-Oncology Associates is partnering with many research networks, both in Georgia and across the United States, to continuously enhance the delivery of state-of-the-art cancer care.

Our physicians are affiliated with the following entities:
Atlanta Regional Community Clinical Oncology Program (ARCCOP): The Community Clinical Oncology Program (CCOP) was initiated by the National Cancer Institute (NCI) in 1983 to provide community hospitals access to a wide range of clinical research studies. Prior to this, a patient had to travel to one of a few select research institutions in the country or to the NCI itself to receive the newest treatments. This meant leaving familiar surroundings of home, family and workplace. As well, oncology physician specialists in your community wanted to be part of the search for answers to cure cancer and to offer you the best treatments available. The ARCCOP, on average, has approximately 40-50 clinical trials open.

UCLA/Translational Oncology Research Institute (TORI): TORI is a UCLA based Network that consists of investigators located at various research sites throughout the US and internationally that collaborate to conduct large-scale studies addressing therapeutics and cancer pharmaceuticals. The GOP has contracted with TORI to be a part of and participate in the TORI network.


National Oncology Alliance Online Collaborative Oncology Group (NOA-OCOG): The NOA-OCOG Research Alliance brings together a large number of community-based oncologists capable of participating in clinical trials and matches them to clinical trials sponsored by biotechnology and pharmaceutical companies. OCOG is a research organization that facilitates the ability of private-practice, community-based oncologists to participate in clinical research studies, with access to novel cancer drugs through the latest and most pivotal clinical research studies.